Event Details

CE Program/Activity
 Low Vision Grand Rounds April 23, 2026
Provider
 Envision University
View more by this Provider
Location
 Wichita, KS - Available to attend in-person or via livestream webinar. In-person attendees: Envision, 610 N. Main, Wichita, KS 67203 . Livestream webinar attendees via link. The cost for this 2-hour educational event is $60 per person. RSVP https://www.envisionuniversityevents.com/APR23GrandRounds2026. Registrations are requested by April 21, 2026. If you have any special needs and requests, or questions regarding accessibility, please contact us at info@envisionuniversity.org.
Date(s)
 April 23, 2026 - April 23, 2026
CE Hours
 2
Contact Information
 Michael Epp michael.epp@envisionus.com
Registration Information
 Available to attend in-person or via livestream webinar. In-person attendees: Envision, 610 N. Main, Wichita, KS 67203 . Livestream webinar attendees via link. The cost for this 2-hour educational event is $60 per person. RSVP https://www.envisionuniversityevents.com/APR23GrandRounds2026. Registrations are requested by April 21, 2026. If you have any special needs and requests, or questions regarding accessibility, please contact us at info@envisionuniversity.org.
Fees
 60
Description of CE Program/Activity
 Uveitis: Breaking Down Inflammation. This case study presentation explores different cases of uveitis, using them as a basis for understanding this condition. The session will address the primary causes of uveitis, as well as strategies for diagnosis and treatment. Key topics will include relevant laboratory tests and systemic treatments. A specific case of uveitic glaucoma will provide an in-depth analysis of how uveitis can lead to glaucoma. Instruction Level: Intermediate. Learning Objectives: 1. Describe the major etiologic categories and pathophysiologic mechanisms of uveitis in adult patients.2. Identify key anterior and posterior segment clinical signs of uveitis on slit-lamp biomicroscopy and fundus examination. 3. Select appropriate laboratory and imaging studies to evaluate patients with suspected infectious and noninfectious uveitis. 4. Formulate evidence-based initial treatment plans for common uveitis presentations, including indications for topical, periocular, and systemic therapies. 5. Adjust uveitis management strategies in collaboration with other specialists (e.g., rheumatology, occupational therapy, vision rehabilitation) to optimize systemic disease control and ocular outcomes. 6. Recognize sight-threatening complications of uveitissuch as uveitic glaucoma, synechiae, and macular involvementand outline timely intervention strategies.